glp-1 active ingredient Support System Sample Pack – SoWell GLP-1 Analogues: Diabetes & Weight
Description
Rev Latinoam Enferm 16:238244 Iglay K, Hannachi H, Joseph Howie P, Xu J, Li X, Engel SS, Rajpathak S (2016) Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
The medication was only approved in 2022 and 2023, making it too new for meaningful pregnancy outcome data to have accumulated

How often it happens depends on the drug and the dose

At 24 months, there was a 68% reduction in papilledema risk

Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, et al
When food enters the digestive system, specialised cells in the gut release GLP-1, which stimulates insulin secretion, slows gastric emptying, and promotes feelings of satiety
